Debut Plus

₹1,337

▼ -9.02 -0.67%

17 Jul 2026

NSE Listed

Concord Biotech Limited (CONCORDBIO)

Volume: 70,385Avg Vol 1W: 1,23,715.8Avg Vol 1M: 1,31,387.652W Range:₹987₹1,980
NSE BSE www.concordbiotech.com
Key Ratios
Checked 6h ago
Market Cap₹14,081 Cr
Current Price₹1,337
Previous Close₹1,346.02
High / Low (52w)₹1,980 / ₹987
Volume70,385
Avg Vol (1W)1,23,715.8
Avg Vol (1M)1,31,387.6
Stock P/E159.1
Book Value₹192.81
Dividend Yield56%
ROE12.94%
ROA11.6%
Revenue (TTM)₹1,245 Cr
Revenue Growth18%
Profit Margin24.73%
Total Debt₹0 Cr
Shares Outstanding10 Cr
Face Value₹1
EPS (TTM)₹22.8
P/B6.97
Debt / Equity0
50 DMA₹1,251.48
200 DMA₹1,269.04
Day change-0.67%
Price Chart
₹1,337▼ 30.38% · 1Y
₹1944₹10151.1Cr
2025-07-17
2026-07-16

20-day avg volume: 1.3L shares

Pros
  • Pays a dividend yield of 56.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 14% YoY.
  • Stock trades at a high P/E of 159.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹216 Cr₹310 Cr₹244 Cr₹430 Cr₹204 Cr₹247 Cr₹278 Cr₹326 Cr
EBITDA₹78 Cr₹133 Cr₹99 Cr₹185 Cr₹57 Cr₹83 Cr₹90 Cr₹114 Cr
Net Profit₹60 Cr₹96 Cr₹76 Cr₹140 Cr₹44 Cr₹64 Cr₹64 Cr₹89 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹544 Cr₹631 Cr₹736 Cr₹888 Cr₹1,051 Cr₹1,245 Cr
EBITDA₹214 Cr₹314 Cr₹247 Cr₹325 Cr₹412 Cr₹496 Cr
Net Profit₹169 Cr₹235 Cr₹175 Cr₹240 Cr₹308 Cr₹372 Cr
EPS177.82246.9716.7222.9529.4535.52
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹941 Cr₹1,183 Cr₹1,313 Cr₹1,514 Cr₹1,701 Cr₹2,034 Cr
Total Liabilities₹170 Cr₹183 Cr₹210 Cr₹224 Cr₹174 Cr₹222 Cr
Equity₹770 Cr₹999 Cr₹1,103 Cr₹1,290 Cr₹1,527 Cr₹1,813 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr
Investing₹-114 Cr₹-112 Cr₹-158 Cr₹-155 Cr₹-160 Cr
Financing₹-43 Cr₹-100 Cr₹-85 Cr₹-99 Cr₹-99 Cr
Free Cash Flow₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr
Shareholding
Promoter 44.08% Institutions 17.02% Public 38.9%
Efficiency & Working Capital
ROCE17.1%
Interest Coverage421.3
Dividend Payout—
Debtor Days159 d
Inventory Days73 d
Payable Days34 d
Cash Conversion Cycle197 d
Working Capital Days232 d
Shareholding Details

As of 2026-03-31

Promoter44.1%
FII7.8%
DII9.2%
Institutions17%
Public38.9%
Promoter Pledge0%
No. of Shareholders82,249
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodAug 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%
FIIs4.6%7.3%7%6.5%7.1%8.1%8.3%9.4%9.1%8%7.6%7.8%
DIIs4.9%8.2%8.1%8.5%10.4%9.9%9.7%9.2%8.9%9.6%9.6%9.2%
Public46.4%40.4%40.8%41%38.4%37.9%37.9%37.4%37.9%38.3%38.8%38.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3,77,5721,00,92787,48683,29680,73784,29882,00481,21982,04582,65081,81582,249
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sudhir Kumar VaidShareholding of Promoter and Promoter Group28.8%3.02 Cr
Manju VaidShareholding of Promoter and Promoter Group9.6%99,87,636
Aryavir Jhunjhunwala Discretionary TrustPublic Shareholding8%83,99,754
Aryaman Jhunjhunwala Discretionary TrustPublic Shareholding8%83,99,754
Nishtha Jhunjhunwaladiscretionary TrustPublic Shareholding8%83,99,732
Sudman Consultants LlpShareholding of Promoter and Promoter Group4.5%47,52,000
Government Pension Fund GlobalPublic Shareholding3%31,28,149
1575773 Ontario IncPublic Shareholding2%20,92,325
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap FundPublic Shareholding1.9%19,94,581
Dsp Small Cap FundPublic Shareholding1.8%18,28,652
Axis Max Life Insurance Limited A/c Reversionary Bonus Participating - EquityPublic Shareholding1.5%15,87,162
Ravindra Raichand DharamshiPublic Shareholding1.2%12,56,432
Chanakya Corporate Services Pvt LtdPublic Shareholding1.1%11,63,833
Ohm Stock Broker Private LimitedPublic Shareholding1.1%11,00,000
Ankur Sudhir VaidShareholding of Promoter and Promoter Group0.6%5,86,520
Vaid Megha AnkurShareholding of Promoter and Promoter Group0.5%5,47,008
Sonal KumraShareholding of Promoter and Promoter Group0.1%73,920
Aarav VaidShareholding of Promoter and Promoter Group0%0
Myra VaidShareholding of Promoter and Promoter Group0%0
Gaurav KumraShareholding of Promoter and Promoter Group0%0
Concord Lifegen LimitedShareholding of Promoter and Promoter Group0%0
Clean Max Everglades Private LimitedShareholding of Promoter and Promoter Group0%0
Concord Biotech Japan KkShareholding of Promoter and Promoter Group0%0
Celliimune Biotech Private LimitedShareholding of Promoter and Promoter Group0%0
Stellon Biotech Inc.Shareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sudhir Kumar Vaid00%2026-03-31
Manju Vaid00%2026-03-31
Ankur Sudhir Vaid00%2026-03-31
Vaid Megha Ankur00%2026-03-31
Sonal Kumra00%2026-03-31
Sudman Consultants Llp00%2026-03-31
Aarav Vaid00%2026-03-31
Myra Vaid00%2026-03-31
Gaurav Kumra00%2026-03-31
Concord Lifegen Limited00%2026-03-31
Clean Max Everglades Private Limited00%2026-03-31
Concord Biotech Japan Kk00%2026-03-31
Board of Directors
NameDesignationYear
SUDHIR JAIRAM VAIDChairman / Executive Director / M D / Promoter2025
ANKUR VAIDED / Joint MD / CEO / Promoter2025
Ravi KapoorNon Executive Director2025
Rajiv AgarwalNon Executive Director2025
BHARTI KHANNAIndependent Non Exe. Director2025
Amitabh ThakoreIndependent Non Exe. Director2025
Arvind AgarwalIndependent Non Exe. Director2025
Jayaram EaswaranIndependent Non Exe. Director2025
Mandayam Chakravarthy SriramanIndependent Non Exe. Director2025
Hina Ronak PatelCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Within India₹662 Cr55.1%
America₹138 Cr11.5%
Others₹400 Cr33.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1111010
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-24Dividend (7.55/- per share)Final
dividend2025-09-03₹10.7 (1070%)Final
forthcoming—Book ClosureAGM & 755% Final Dividend
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202631033495132
202614000014
2026150449588
Insider / Designated-Person Trades

11 recent disclosure(s)

Prakash Lalchand SajnaniDisposal · 5,000
Chandrashekhar Mukundrao ChawanDisposal · 1,000
Devang BhattDisposal · 3,000
Kanishka KapoorDisposal · 10,000
Ravi KapoorDisposal · 10,000
Rajendra ModiDisposal · 4,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market28/05/2024 · 35,48,211
Company Information
Incorporated1984
ChairmanSUDHIR JAIRAM VAID
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.concordbiotech.com ↗

📍 1482-86 Trasad Road, Dholka, Ahmedabad, Gujarat, 382225

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Comfort Intech Ltd.Committed Cargo Care Ltd.Compuage Infocom Ltd.Compucom Software Ltd.Commercial Syn Bags Ltd.Container Corp of Ind Ltd.Confidence Petro Ind Ltd.Connplex Cinemas LimitedConso. Fin. & Hold. Ltd.Continental Seed Chem Ltd.Control Print LimitedCool Caps Industries Ltd.All “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search